SCHEMBL7319451

SCHEMBL7319451

CC(NS(=O)(=O)N1CCN(C(=O)Nc2ccc(Oc3ccccc3)cc2)CC1)C(=O)NO

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.50
FAAH O00519 6/20 0.49
GAA P10253 1/20 0.47
NPY5R Q15761 2/20 0.47
PDGFRB P09619 4/20 0.47
MAPT P10636 1/20 0.45
FLT3 P36888 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
RECQL P46063 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MMP1 P03956 1/20 0.45
MMP2 P08253 1/20 0.45
MMP3 P08254 1/20 0.45
MMP7 P09237 1/20 0.45
MMP9 P14780 1/20 0.45
MMP13 P45452 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4672695 1.00 KMT2A (0.50) KMT2AFAAHGAANPY5RPDGFRB
SCHEMBL4673278 0.84 KMT2A (0.49) KMT2AGAAMAPTCA12CA1
SCHEMBL4675351 0.84 KMT2A (0.49) KMT2AGAAMAPTCA12CA1
SCHEMBL8096541 0.79 FAAH (0.51) KMT2AFAAHGAANPY5RPDGFRB
SCHEMBL7314720 0.78 ALDH1A1 (0.48) MAPTRECQLSMN1; SMN2MMP1MMP2
SCHEMBL7314715 0.78 ALDH1A1 (0.48) MAPTRECQLSMN1; SMN2MMP1MMP2
SCHEMBL8096543 0.76 FAAH (0.49) KMT2AFAAHGAANPY5RPDGFRB
SCHEMBL4673443 0.74 MMP1 (0.53) KMT2AGAAMAPTCA12CA1
SCHEMBL4673444 0.74 MMP1 (0.53) KMT2AGAAMAPTCA12CA1
SCHEMBL311835 0.73 SMN1; SMN2 (0.66) KMT2AFAAHPDGFRBMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376506-B1 REACTING SULFAMOYL OXAZOLIDONE WITH (1,2,3,4)-TETRAHYDRO-BETA-CARBOLINE TO FORM INHIBITOR; USED TO TREAT ARTHRITIS, OSTEOPOROSIS, PERIODONTAL DISEASE, CARDIOVASCULAR DISEASES, MULTIPLE SCLEROSIS, AND TUMORS SYNTEX (U.S.A.) LLC 2002-04-23 US disclosed